PhaseBio Pharmaceuticals, Inc. (PHAS)
Revenue
$208.00K
Quarterly · Period ending: · USD
PHAS Revenue
Latest reported$208.00Kperiod ending
Latest reported$208.00Kperiod ending
PHAS Quarterly Revenue ($0.00 → $208.00K)
Quarterly revenue
High-resolution chart · PNG
PHAS revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue (USD) |
|---|---|
| 208,000 | |
| 117,000 | |
| 158,000 | |
| 335,000 | |
| 10,338,000 | |
| 0 | |
| 0 | |
| 241,000 | |
| 703,000 | |
| 320,000 | |
| 764,000 | |
| 241,000 | |
| 703,000 | |
| 653,000 | |
| 257,000 | |
| 411,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |